Across TCGA pan-cancer cohorts, LINC01947 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC01947’s most consistent transcriptional readouts.
The strongest signal is observed in prostate adenocarcinoma (PRAD), where LINC01947 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01947 is over-expressed in tumor.
PRAD and KIRC are the cancer types where LINC01947 tumor–normal differential expression is most reproducible.